InnovaRx Innova Health Strategies
Pricing Sign in

Respiratory Tract Neoplasms

MeSH D012142

A MeSH concept, not an ICD-10 code. It usually spans several ICD-10 codes.

Contraindicated with · 2

sorafenib sorafenib tosylate

Indicated for · 108

adagrasib afatinib afatinib dimaleate alectinib alectinib hydrochloride amivantamab amivantamab-lpuj amivantamab-vmjw atezolizumab atezolizumab-tqjs berahyaluronidase alfa berahyaluronidase alfa-pmph bevacizumab bevacizumab-adcd bevacizumab-awwb bevacizumab-bvzr bevacizumab-maly bevacizumab-nwgd bevacizumab-tnjn brigatinib capmatinib capmatinib hydrochloride carboplatin carmustine ceritinib cholecalciferol chromic phosphate P32 cisplatin crizotinib cyclophosphamide cyclophosphamide anhydrous cyclophosphamide lyophilized dacomitinib dacomitinib anhydrous dictamnine docetaxel docetaxel anhydrous doxorubicin doxorubicin hydrochloride doxorubicin hydrochloride liposome ensartinib ensartinib hydrochloride entrectinib erlotinib erlotinib hydrochloride etoposide etoposide phosphate gefitinib gemcitabine gemcitabine hydrochloride hydroxyurea ifosfamide irinotecan irinotecan hydrochloride lazertinib lazertinib mesylate lomustine lurbinectedin mechlorethamine mechlorethamine hydrochloride methotrexate methotrexate sodium mobocertinib mobocertinib succinate necitumumab nivolumab nivolumab-nvhy nivolumab-rmbw osimertinib osimertinib mesylate paclitaxel paclitaxel protein-bound pembrolizumab pembrolizumab-pmph pemetrexed pemetrexed dipotassium pemetrexed disodium pemetrexed disodium hemipentahydrate pemetrexed disodium heptahydrate pemetrexed monohydrate pemetrexed tromethamine anhydrous pralsetinib procarbazine procarbazine hydrochloride ramucirumab selpercatinib sevabertinib sotorasib sunvozertinib taletrectinib taletrectinib adipate tarlatamab tarlatamab-dlle telisotuzumab telisotuzumab vedotin telisotuzumab vedotin-tllv teniposide topotecan topotecan hydrochloride trametinib trametinib dimethyl sulfoxide vinblastine vinblastine sulfate vinorelbine vinorelbine tartrate zenocutuzumab zenocutuzumab-zbco zongertinib